Development For Ipsen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Development for ipsen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Development For Ipsen Today - Breaking & Trending Today

Ipsen updates on E.U. Marketing Authorisation Application for odevixibat in Alagille syndrome

Positive opinion from Committee for Medicinal Products for Human Use recommending approval of Bylvay® (odevixibat) based on Phase III ASSERT clinical-trial data in Alagille syndrome (ALGS) already received in July 2023Committee for Orphan Medicinal Products confirms a negative opinion of its review recommending not to maintain the orphan designation for Bylvay in ALGSIpsen plans to submit a new Marketing Authorisation Application for the treatment of ALGS by the end of 2023 under a new brand nam ....

United States , France General , United Kingdom , Jennifer Moore , Ioana Piscociu , Christelle Huguet , Amy Wolf , Asia Pacific , Nicolas Bogler , Ipsen Euronext , Head Of Corporate Brand Strategy Communications , Committee For Orphan Medicinal Products , Committee For Medicinal Products Human , European Society For Pediatric Gastroenterology Hepatology , Head Of Research , Development For Ipsen , Global Corporate Communications , Committee For Medicinal Products Human Use , European Medicines Agency , Albireo Pharma Inc , Medicinal Products , Human Use , Orphan Medicinal Products , Marketing Authorisation Application , Executive Vice President , Orphan Medicinal Product Regulation ,